Lymph Node Haematopoietic, Histiocytic, Dendritic Proliferations and Other Lymphoid Organs

Zeppa, Pio; Cozzolino, Immacolata

doi:10.1159/000478886

Cited by 1 publication

(1 citation statement)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indeed, S100 may be expressed by some carcinomas, some mesenchymal tumors, and Langerhans cell histiocytosis. 40 , 41 , 42 SOX10 is more specific than S100 as a melanocytic marker, but it is not entirely specific, because it shows positive findings in some mesenchymal tumors, diffuse astrocytomas, and pleomorphic undifferentiated sarcomas. 41 , 43 , 44 A differential diagnosis involving malignant nerve sheath tumor and clear cell sarcoma may be particularly challenging, because the immunophenotypes of these neoplasms may overlap with MM.…”

Section: Advances In the Cytologic Diagnosis Of MMmentioning

confidence: 99%

Cytologic diagnosis of metastatic melanoma by FNA: A practical review

Ronchi

Montella

Marino

et al. 2021

Cancer Cytopathology

Self Cite

View full text Add to dashboard Cite

Malignant melanoma (MM) is a highly aggressive neoplasm with a growing worldwide incidence. It is not uncommon that the disease is already metastatic at the time of the first diagnosis. Regional lymph nodes and skin are the first and most common metastatic sites, followed by distant visceral sites (lungs, liver, and central nervous system) and bone. In this clinical setting, fine-needle aspiration (FNA) often represents the first diagnostic approach. FNA is a useful tool to obtain a rapid and accurate diagnosis, in conjunction with ancillary techniques and molecular analysis, as recommended by recent guidelines.The aim of this review was to describe the cytomorphology, immunocytochemical tools, and molecular tools used for the diagnosis of MM metastases on FNA. Cancer Cytopathol 2021;0:1-12.

show abstract